Cyclerion Therapeutics Inc — Balance Sheet (NASDAQ:CYCN) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 115.38 M59.33 M18.08 M13.37 M9.57 M Total liabilities 55.88 M11.09 M7.63 M2.09 M725 K Total equity 59.49 M48.25 M10.45 M11.29 M8.85 M Total liabilities & shareholders' equities 115.38 M59.33 M18.08 M13.37 M9.57 M Total debt 7.01 M3.5 M——— Net debt -47.39 M-50.46 M———

뉴스

사이클러리온, FDA로부터 우울증 치료제 개발 관련 피드백 받아

Cyclerion receives FDA feedback on depression treatment development

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Acrivon Therapeutics (NASDAQ:ACRV), AZZ (NYSE:AZZ)

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression - Slideshow (NASDAQ:CYCN) 2026-01-07

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

US Stocks Mixed; Nasdaq Gains Over 50 Points - Alumis (NASDAQ:ALMS), AngioDynamics (NASDAQ:ANGO)

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

사이클레리온 테라퓨틱스, Medsteer 협력 소식에 급등

Cyclerion partners with Medsteer to advance depression treatment platform

Cyclerion Therapeutics stock soars after strategic Medsteer collaboration

Cyclerion Therapeutics, Inc. (CYCN) Discusses on Pioneering a New Era in Neuropsychiatric Therapies (NASDAQ:CYCN) 2025-09-24